FDAnews
www.fdanews.com/articles/114858-genzyme-8217-s-oral-gaucher-therapy-meets-goal-of-trial

Genzyme’s Oral Gaucher Therapy Meets Goal of Trial

February 23, 2009
Genzyme Corp., a Cambridge biotechnology company, said that its experimental oral treatment for Gaucher disease, a rare genetic disorder, met the main goal of a mid-stage clinical trial.
boston.com